From Name

From Email

To Name

To Email

Message

Gardasil 9 for the prevention of some head and neck cancers: Measuring the benefit

from Cancer Therapy Advisor

Gardasil 9 for the prevention of some head and neck cancers: Measuring the benefit Cancer Therapy Advisor The U.S. Food and Drug Administration has approved Merck Sharp & Dohme Corp.'s human papillomavirus vaccine Gardasil 9 for the prevention of oropharyngeal cancers and other head and neck cancers caused by nine different HPV strains. The accelerated approval was granted based on evidence that the vaccine can prevent HPV-related anogenital infections and a clinical trial to evaluate its ability to prevent HPV-related throat infections in men is ongoing. READ MORE

more